Magnetic resonance imaging-proton density fat fraction (MRI-PDFF) to predict treatment response on NASH liver biopsy: a secondary analysis of the resmetirom randomized placebo-controlled phase 2 clinical trial
2020 ◽
Vol 18
(8)
◽
pp. 1842-1850.e6
◽
2019 ◽
Vol 70
(1)
◽
pp. e69-e70
◽
2019 ◽
Vol 50
(6)
◽
pp. 1905-1913
◽
2020 ◽
Vol 18
(8)
◽
pp. e95-e96
2018 ◽
Vol 155
(2)
◽
pp. 307-310.e2
◽